Aquestive Therapeutics, Inc.
USD4.16
+0.00 (+0.00%)
CEO
Daniel Barber
IPO Date
2018-07-25
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
Open
$4.17
Prev. Close
$4.16
Day Low
$4.13
Day High
$4.24
52W Low
$2.93
52W High
$7.55
Market Cap
$0.41B
Volume
1.47M
| -7.0 |
| 31 Dec 2023 | FY | 58.8% | -15.6% | 7.4% | -13.7% | -0.31 | 2.24 | -15.7 |
| 31 Dec 2022 | FY | 59.3% | -114.1% | 45.9% | -95.3% | -0.48 | 1.01 | -0.8 |
| 31 Dec 2021 | FY | 70.5% | -138.8% | 85.9% | -113.8% | -0.69 | 2.15 | -2.1 |
| 31 Dec 2020 | FY | 71.7% | -121.7% | 115.0% | -88.7% | -0.83 | 2.11 | -3.2 |
| 31 Dec 2019 | FY | 61.3% | -125.9% | 1082.1% | -84.4% | -9.86 | 3.68 | -2.2 |
| 31 Dec 2018 | FY | 68.9% | -91.0% | -608.9% | -70.7% | 4.68 | 2.25 | -2.1 |
| 31 Dec 2017 | FY | 70.4% | -13.4% | 33.8% | -20.7% | -1.72 | 1.83 | -35.9 |
| 31 Dec 2016 | FY | 68.4% | -18.5% | 54.6% | -24.4% | -2.20 | 2.16 | -41.0 |
| -6.2 |
| 30 Sept 2025 | Q3 | 64.8% | -120.6% | 375.9% | -9.4% | -31.36 | 5.93 | -10.0 |
| 30 Jun 2025 | Q2 | 54.4% | -135.4% | 18.7% | -14.5% | -0.55 | 3.53 | -6.1 |
| 31 Mar 2025 | Q1 | 58.1% | -263.0% | 37.6% | -22.4% | -0.64 | 4.87 | -3.0 |
| 31 Dec 2024 | Q4 | 61.9% | -143.7% | 28.4% | -16.8% | -0.63 | 4.68 | -4.8 |
| 30 Sept 2024 | Q3 | 67.2% | -85.0% | 25.3% | -10.5% | -0.81 | 6.37 | -9.9 |
| 30 Jun 2024 | Q2 | 77.5% | -13.7% | 7.7% | -2.3% | -1.01 | 7.49 | -20.3 |
| 31 Mar 2024 | Q1 | 63.6% | -106.4% | 35.3% | -9.9% | -0.95 | 6.28 | -5.9 |
| 31 Dec 2023 | Q4 | 64.6% | -61.4% | 7.6% | -14.1% | -0.31 | 2.24 | -4.3 |